Sana Biotechnology Reports Fourth Quarter and 2020 Financial Results and Business Updates
Expects to present data at multiple scientific conferences in 2021 2020 year-end cash position of…
Expects to present data at multiple scientific conferences in 2021 2020 year-end cash position of…
Cash runway into the second half of 2023 Announced positive interim data from EQUATE study…
Webinar To Be Held on Tuesday, March 30th at 10am Eastern Time YAVNE, Israel, March…
– Initiation of BIO89-100 Phase 2b NASH trial planned in 1H21 – – NASH histology…
Fourth patient treated in pivotal Phase 3 VIITAL™ study of EB-101 in RDEB after successful…
MALVERN, Pa., March 24, 2021 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
Mechelen, Belgium; 24 March 2021; 21.01 CET; Galapagos (Euronext & Nasdag; GLPG) announced today that…
03_24 PR Image The 3 Distinct Tauri-Pet™ SKUs Commercial Launch of Tauri-Pet™ Product Line is…
2020 annual results Revenue in line with forecasts despite the health crisis: -12.8% at current…
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments European Patients…
CAMBRIDGE, Mass., March 24, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical…
Allows focus on China and global clinical development and market launches of key Oncology/Immunology assets HONG…
SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,”…
TORONTO, March 24, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
Vafidemstat displayed good safety and tolerability in healthy young and elderly volunteers Paper confirms vafidemstat…
TORONTO, March 24, 2021 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX…
CAMBRIDGE, Mass., March 24, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…
Mandarin session on April 7, 2021 and English session on April 26, 2021 for investors…
SOUTH SAN FRANCISCO, Calif., March 24, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a…
GARDEN CITY, N.Y., March 24, 2021 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a…